Antitrombotisko līdzekļu lietošanas riski senioru vidū.
No Thumbnail Available
Date
2023
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Rīgas Stradiņa universitāte
Rīga Stradiņš University
Rīga Stradiņš University
Abstract
Insults ir izplatīts nāves cēlonis Latvijā. Pēc Slimību un profilakses centra datiem 2021. gadā laikā ar diagnozi -išēmisks insults mira 1399 pacienti un - hemorāģisks insults- 420 pacienti. [1] Pasaulē sirds išēmiskā slimība un miokarda infarkts ir populārākie nāves cēloņi. Šo slimību prevencijai pacientiem ar augstāku sirds slimību risku tiek nozīmēta antitrombotiskā terapija. Nereti tie ir vecāka gada gājuma cilvēki. [2]
Pētījuma veikšanai tika izmantota aprakstošā un anketēšanas metode, kur tika aptaujāts 71 dalībnieks, kurš regulāri lieto antitrombotiskos līdzekļus. Tika noskaidroti demogrāfiskie dati- pacienta dzimums, vecums, dzīvesvieta. Atzīmējot ikdienā lietoto antitrombotisko līdzekli un lietošanas ilgumu, pacients varēja norādīt, vai un kādas blaknes izjutis terapijas laikā, vai kādreiz nācies saskarties ar kritienu epizodēm, ar zilumu parādīšanos. Atbildot uz jautājumu par pēdējo klātienē notikušo vizīti, un ,viņuprāt, ārsta un farmaceita konsultācijas nepieciešamību vienlaikus iegādājoties antitrombotiskos līdzekļus, uztura bagātinātājus un medikamentus, kā arī finansiālo ietekmi terapijas regulārai nodrošināšanai.
Pētījuma '''Antitrombotisko līdzekļu lietošanas riski senioru vidū'' mērķis bija noskaidrot zāļu vielu un uztura bagātinātāju iespējamo mijiedarbības risku, ietekmi uz pacientiem vecumā virs 55 gadiem un kas ikdienā lieto antitrombotiskos līdzekļus. Praksē novērojot pacientu paradumus zāļu izvēlē, farmaceita un ārsta lomu lēmuma pieņemšanā par uztura bagātinātāju, zāļu vielu un antitrombotisko līdzekļu iegādi un lietošanu.
Visbiežāk lietotais medikaments aptaujāto pacientu vidū bija aptiekās brīvi pieejams bezrecepšu medikaments- acetilsalicilskābe mazās devās. Apkopojot datus par pacientu novērotajām blakusparādībām, tika noskaidrots, ka tieši mazu devu acetilsalicilskābes lietošana visbiežāk izsauc dažādas izcelsmes asiņošanu.
Stroke is a common cause of death in Latvia. According to data from the Centre for Disease control and Prevention, in 2021, 1,399 patients died with a diagnosis of ischemic stroke and 420 patients died of hemorrhagic stroke. The most popular causes of death in the world are ischemic heart disease and myocardial infarction. For the prevention of these diseases an antithrombotic therapy is prescribed for patients with a higher risk of heart disease. Often these are elderly people. To conduct the research, the descriptive and survey method was used, with 71 interviewed respondent who regularly use antithrombotic medication. Demographic data were determined – patient’s gender, age, place of residence. By specifying the antithrombotic agent used daily and the duration of use, the patient could indicate whether and what side effects were experienced during the therapy, or if episodes of falls, with visible bruises were ever faced. Answering the question about the last face-to-face visit, and, in their opinion, the need for a doctor's and pharmacist's consultation when purchasing antithrombotic agents, nutritional supplements and medications, as well as the financial impact of regular provision of therapy. The aim of the research ''Risks of antithrombotic medication use among seniors'' was to find out the possible interaction risk of medication substance and nutritional supplements, the effect on patients over 55 years of age who use antithrombotic medication on a daily basis. In practice, observing the habits of patient’s choice of medication, the role of pharmacists and doctors in making decisions about the purchase and use of nutritional supplements, medicine substances and antithrombotic medication. The most frequently used medication among the affected patients was - acetylsalicylic acid in small doses, that is a non-prescription medication freely available in pharmacies. When collecting data about the patients observed side effects, it was found that the use of small doses of acetylsalicylic medication most often causes bleeding of various origins.
Stroke is a common cause of death in Latvia. According to data from the Centre for Disease control and Prevention, in 2021, 1,399 patients died with a diagnosis of ischemic stroke and 420 patients died of hemorrhagic stroke. The most popular causes of death in the world are ischemic heart disease and myocardial infarction. For the prevention of these diseases an antithrombotic therapy is prescribed for patients with a higher risk of heart disease. Often these are elderly people. To conduct the research, the descriptive and survey method was used, with 71 interviewed respondent who regularly use antithrombotic medication. Demographic data were determined – patient’s gender, age, place of residence. By specifying the antithrombotic agent used daily and the duration of use, the patient could indicate whether and what side effects were experienced during the therapy, or if episodes of falls, with visible bruises were ever faced. Answering the question about the last face-to-face visit, and, in their opinion, the need for a doctor's and pharmacist's consultation when purchasing antithrombotic agents, nutritional supplements and medications, as well as the financial impact of regular provision of therapy. The aim of the research ''Risks of antithrombotic medication use among seniors'' was to find out the possible interaction risk of medication substance and nutritional supplements, the effect on patients over 55 years of age who use antithrombotic medication on a daily basis. In practice, observing the habits of patient’s choice of medication, the role of pharmacists and doctors in making decisions about the purchase and use of nutritional supplements, medicine substances and antithrombotic medication. The most frequently used medication among the affected patients was - acetylsalicylic acid in small doses, that is a non-prescription medication freely available in pharmacies. When collecting data about the patients observed side effects, it was found that the use of small doses of acetylsalicylic medication most often causes bleeding of various origins.
Description
Farmācija
Pharmacy
Veselības aprūpe
Health Care
Pharmacy
Veselības aprūpe
Health Care
Keywords
blakusparādību riski, antitrombotiskie līdzekļi, trombi, blakusparādības, rivaroksabāns, dabigatrāns, apiksabāns, klopidogrels, acetilsalicilskābe, tikagrelors, varfarīns, risks of sideffects, antithrombotic medication, thrombs, sideffects, rivaroxaban, dabigatran, apiksaban, clopidogrel, acetylsalicylic acid, ticagrelor, warfarin